Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000599399 | SCV000710089 | uncertain significance | not provided | 2024-07-26 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 2 amino acids in a non-repeat region; In silico analysis indicates that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ce |
RCV000599399 | SCV001150500 | uncertain significance | not provided | 2019-02-01 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001262125 | SCV001439887 | uncertain significance | Methylmalonic acidemia with homocystinuria, type cblX | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001262125 | SCV002116056 | uncertain significance | Methylmalonic acidemia with homocystinuria, type cblX | 2021-09-17 | criteria provided, single submitter | clinical testing | This variant, c.4983_4988del, results in the deletion of 2 amino acid(s) of the HCFC1 protein (p.Val1662_Thr1663del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with HCFC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 503794). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002532688 | SCV003667756 | uncertain significance | Inborn genetic diseases | 2022-10-18 | criteria provided, single submitter | clinical testing | The c.4983_4988delCGTGAC (p.V1662_T1663del) alteration is located in exon 20 (coding exon 20) of the HCFC1 gene. This alteration consists of an in-frame deletion of 6 nucleotides between nucleotide positions c.4983 and c.4988, resulting in the deletion of 2 residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV000599399 | SCV005192349 | uncertain significance | not provided | criteria provided, single submitter | not provided |